{{Rsnum
|rsid=651477
|Chromosome=2
|position=118638115
|Orientation=minus
|GMAF=0.242
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 47.7 | 42.3 | 9.9
| HCB | 75.2 | 24.8 | 0.0
| JPT | 70.5 | 26.8 | 2.7
| YRI | 62.3 | 33.6 | 4.1
| ASW | 61.4 | 31.6 | 7.0
| CHB | 75.2 | 24.8 | 0.0
| CHD | 65.7 | 31.5 | 2.8
| GIH | 37.0 | 49.0 | 14.0
| LWK | 59.1 | 31.8 | 9.1
| MEX | 53.4 | 37.9 | 8.6
| MKK | 55.8 | 42.3 | 1.9
| TSI | 64.7 | 31.4 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000007
|OR=1.38
|ORtxt=[NR]
}}

{{PharmGKB
|RSID=rs651477
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 978 cases, 883 controls; Replication Sample Size: NR); (Region: 2q14.2; Reported Gene(s): EN1; Risk Allele: rs651477-?); (p-value= 0.000007).This variant is associated with Multiple sclerosis.
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740716
}}

{{PMID Auto
|PMID=20944657
|Title=Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs651477
|overall_frequency_n=33
|overall_frequency_d=128
|overall_frequency=0.257812
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=29
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}